Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

News provided by

Apr 14, 2026, 08:50 ET

The entrepreneur and mother of four shares her breast augmentation journey, from consultation to post-op, with Natrelle^® breast implants.

As a champion of authenticity, Lichy hopes her transparency will help normalize the conversation around breast surgery.

IRVINE, Calif., April 14, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) has teamed up with New York-based entrepreneur and television personality, Erin Lichy. Lichy is opening up about her recent breast augmentation with market-leading Natrelle^® breast implants in an effort to promote transparency and normalize conversations around aesthetic procedures. As a mom of four, and after years of breastfeeding, Lichy's decision to pursue breast augmentation is a part of her personal journey towards renewed body positivity. By sharing her story, Lichy aims to support other women considering breast surgery.

After breast augmentation with Natrelle® breast implants. Image courtesy of Erin Lichy.

Before breast augmentation with Natrelle® breast implants. Image courtesy of Erin Lichy.

"Motherhood and breastfeeding changed my body in ways I didn't fully expect, and I found myself wanting to feel more like me again," said Erin Lichy. "I didn't originally consider breast implants because I was looking for an understated result, but after sharing my aesthetic goals with board-certified plastic surgeon Dr. Ira Savetsky, we chose Natrelle^® implants. It was a very educational conversation. We talked about projection, profile, the safety of the implant and how they would look on my body. I'm thrilled with my results, and I'm sharing my experience to help other women feel more confident to explore their own options."

As part of her partnership with Natrelle^®, Lichy will be sharing her experience from consultation to post-op across her social media channels.

"Every woman's aesthetic journey is unique. Erin's transparency and willingness to share her story fosters connection for other women," said Nicole Mowad-Nassar, President, Global Allergan Aesthetics and Senior Vice President, AbbVie. "Honest conversations are the first step in helping women who may be interested in breast augmentation feel empowered to schedule a consultation and learn more."

With the most comprehensive range of smooth breast implant options, Natrelle^® is built on a 50-year legacy of innovation in breast aesthetics and offers five profiles and three gummy gel cohesivities¹, giving board-certified plastic surgeons the flexibility to tailor each patient's desired results. Natrelle^® breast implants have a 10-year clinical safety profile backed by a rigorous clinical trial.¹ As more women seek clear, credible information about aesthetic procedures, Natrelle^® continues to prioritize patient education and close partnership with board-certified plastic surgeons.¹

Patients who are inspired by Erin's story can continue fueling the transparent conversation by entering the Faces of Natrelle^® Testimonial Program. The nationwide initiative invites women who have undergone breast augmentation or reconstruction with Natrelle^® implants to share their personal experiences through photos, videos, and written testimonials for a chance to be featured on the brand's social media platforms, and website.

To learn more about eligibility and how to submit your story, visit:

Augmentation Patients: faces.natrelle.com/augmentation
Reconstruction Patients: faces.natrelle.com/reconstruction

To learn more about treatment with Natrelle^® or find a provider, please visit natrelle.com, and follow along on Instagram @natrellebreastaugmentation and @natrellebreastreconstruction.

Natrelle^® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES

Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.

Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.

Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.

Who can get breast implants?
Natrelle^® Breast Implants are approved for the following:

Breast augmentation for women at least 22 years old for silicone-filled implants and for women at least 18 years old for saline-filled implants. Breast augmentation includes primary breast augmentation to increase the breast size and revision surgery to correct or improve the result of a primary breast augmentation
Breast reconstruction. This includes primary breast reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. This also includes revision surgery to correct or improve the result of a primary breast reconstruction

Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:

Women with active infection anywhere in their body
Women with existing cancer or precancer of their breast who have not received adequate treatment for those conditions
Women who are currently pregnant or nursing

What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:

Autoimmune diseases (eg, lupus and scleroderma)
A weakened immune system (eg, taking medications to decrease the body's immune response)
Planned chemotherapy or radiation therapy following breast implant placement
Conditions or medications that interfere with wound healing and blood clotting
Reduced blood supply to breast tissue
Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders
Those with a diagnosis of depression or other mental health disorders should wait for resolution or stabilization of these conditions prior to undergoing breast implantation surgery

What else should I consider?

There is a Boxed Warning for breast implants. Please see bold text at beginning
Many changes to your breasts following implantation are irreversible. If you later choose to have your implants removed and not replaced, you may experience dimpling, puckering, wrinkling, or other cosmetic changes, which may be permanent
Breast implantation is likely not a one-time surgery. The longer implants are in place, the greater the potential risk for complications. You will likely need additional surgeries on your breasts due to complications or unacceptable cosmetic results. Thus, you should also consider the complication rates for later (revision) surgery since you may experience these risks in the future
Cancer treatments and surgery will affect the outcome and timing of breast reconstruction
Breast implants may affect your ability to breastfeed, either by reducing or eliminating milk production
Rupture of a silicone-filled breast implant is most often silent. Even if you have no symptoms, you should have your first ultrasound or MRI at 5 to 6 years after your initial implant surgery and then every 2 to 3 years thereafter regardless of whether your implants are for augmentation or reconstruction. If you have symptoms of or uncertain ultrasound results for breast implant rupture, an MRI is recommended. Additional imaging may be required depending on your medical history and status. The health consequences of a ruptured silicone gel-filled breast implant have not been fully established
Routine screening mammography for breast cancer will be more difficult, and implants may rupture during the procedure. Perform self-examination every month for cancer screening and ask your surgeon to help you distinguish the implant from your breast tissue. Lumps, persistent pain, swelling, hardening, or changes in implant shape should be reported to your surgeon and possibly evaluated with imaging

What are key complications with breast implants?
Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.

Talk to your doctor about other complications.

For more information, see the patient brochures at https://www.rxabbvie.com.

To report a problem with Natrelle^® Breast Implants, please call Allergan^® at 1-800-624-4261.

The sale and distribution of Natrelle^® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

References: